ES2273364T3 - Compuestos dde d[cefemo y composiciones farmaceuticas que contienen estos compuestos. - Google Patents

Compuestos dde d[cefemo y composiciones farmaceuticas que contienen estos compuestos. Download PDF

Info

Publication number
ES2273364T3
ES2273364T3 ES97914600T ES97914600T ES2273364T3 ES 2273364 T3 ES2273364 T3 ES 2273364T3 ES 97914600 T ES97914600 T ES 97914600T ES 97914600 T ES97914600 T ES 97914600T ES 2273364 T3 ES2273364 T3 ES 2273364T3
Authority
ES
Spain
Prior art keywords
mmol
compound
solution
added
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97914600T
Other languages
English (en)
Spanish (es)
Inventor
Yasuhiro Nishitani
Koji Ishikura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2273364T3 publication Critical patent/ES2273364T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
ES97914600T 1996-04-04 1997-04-04 Compuestos dde d[cefemo y composiciones farmaceuticas que contienen estos compuestos. Expired - Lifetime ES2273364T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8-82531 1996-04-04
JP8253196 1996-04-04

Publications (1)

Publication Number Publication Date
ES2273364T3 true ES2273364T3 (es) 2007-05-01

Family

ID=13777098

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97914600T Expired - Lifetime ES2273364T3 (es) 1996-04-04 1997-04-04 Compuestos dde d[cefemo y composiciones farmaceuticas que contienen estos compuestos.

Country Status (11)

Country Link
US (2) US6214818B1 (cg-RX-API-DMAC7.html)
EP (3) EP1544197A1 (cg-RX-API-DMAC7.html)
JP (1) JP4064462B2 (cg-RX-API-DMAC7.html)
KR (1) KR20000005238A (cg-RX-API-DMAC7.html)
CN (2) CN1088711C (cg-RX-API-DMAC7.html)
AT (1) ATE341554T1 (cg-RX-API-DMAC7.html)
AU (1) AU2178497A (cg-RX-API-DMAC7.html)
CA (1) CA2250002C (cg-RX-API-DMAC7.html)
DE (1) DE69736775T2 (cg-RX-API-DMAC7.html)
ES (1) ES2273364T3 (cg-RX-API-DMAC7.html)
WO (1) WO1997037996A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022469A1 (en) * 1996-11-22 1998-05-28 Meiji Seika Kaisha, Ltd. Cephem intermediates and process for producing the same
EP1394159A1 (fr) * 2002-08-13 2004-03-03 Warner-Lambert Company LLC Nouveaux dérivés de thiophène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
TW200637559A (en) * 2005-03-29 2006-11-01 Shionogi & Co 3-propenylcefem derivative
BRPI0713187A2 (pt) * 2006-07-20 2012-10-16 Mehmet Kahraman método de inibir rho-quinase, método de tratamento de doença mediada por rho-quinase, composto e composição farmacêutica
CN101153028B (zh) * 2006-09-30 2010-12-15 山东轩竹医药科技有限公司 具有抗菌抗病毒活性的化合物
AR087342A1 (es) 2011-07-29 2014-03-19 Karyopharm Therapeutics Inc Moduladores del transporte nuclear que contienen hidrazida y sus usos
EA201490406A1 (ru) * 2011-07-29 2014-07-30 Кариофарм Терапевтикс, Инк. Модуляторы ядерного транспорта и их применение
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
SMT202000347T1 (it) 2012-05-09 2020-07-08 Biogen Ma Inc Modulatori di trasporto nucleare e loro usi
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US10202366B2 (en) 2013-03-15 2019-02-12 Karyopharm Therapeutics Inc. Methods of promoting wound healing using CRM1 inhibitors
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
KR102322794B1 (ko) 2013-06-21 2021-11-05 카리오팜 쎄라퓨틱스, 인코포레이티드 핵수송 조절인자 및 이의 용도
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
SG11201700789SA (en) 2014-08-15 2017-02-27 Karyopharm Therapeutics Inc Polymorphs of selinexor
US10709706B2 (en) 2015-12-31 2020-07-14 Karopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
US10526295B2 (en) 2015-12-31 2020-01-07 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
WO2018098472A1 (en) 2016-11-28 2018-05-31 Karyopharm Therapeutics Inc. Crm1 inhibitors for treating epilepsy

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5271239A (en) * 1975-12-10 1977-06-14 Matsushita Electric Ind Co Ltd Electron beam sensitive material
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
JPS6064988A (ja) * 1983-09-21 1985-04-13 Sankyo Co Ltd セフアロスポリン誘導体
JPS60237090A (ja) * 1984-02-21 1985-11-25 Takeda Chem Ind Ltd セフエム化合物
GB8520155D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Compounds
JPS62158290A (ja) * 1985-12-28 1987-07-14 Banyu Pharmaceut Co Ltd 新規セフアロスポリン誘導体
JPS62158291A (ja) * 1986-01-07 1987-07-14 Sagami Chem Res Center セフアロスポリン誘導体
JPH0459730A (ja) * 1990-06-26 1992-02-26 Dai Ichi Seiyaku Co Ltd セフェム系抗生物質含有凍結乾燥製剤
US5202321A (en) * 1991-06-13 1993-04-13 Merck Frosst Canada, Inc. Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosynthesis
JPH05217239A (ja) * 1991-10-31 1993-08-27 Sony Corp 光磁気ディスク記録再生装置
EP0554004A3 (en) * 1992-01-27 1993-11-24 Katayama Seisakusho Cephem compounds and antibacterial agents
JPH0741485A (ja) * 1993-07-30 1995-02-10 Katayama Seiyakushiyo:Kk セフェム誘導体およびそれを含有する抗菌剤

Also Published As

Publication number Publication date
CA2250002C (en) 2008-03-25
US6458950B1 (en) 2002-10-01
CN1290702A (zh) 2001-04-11
CN1129596C (zh) 2003-12-03
CN1088711C (zh) 2002-08-07
WO1997037996A1 (en) 1997-10-16
ATE341554T1 (de) 2006-10-15
EP0893446A1 (en) 1999-01-27
US6214818B1 (en) 2001-04-10
DE69736775T2 (de) 2007-08-23
DE69736775D1 (de) 2006-11-16
EP1544197A1 (en) 2005-06-22
EP1671966A1 (en) 2006-06-21
AU2178497A (en) 1997-10-29
JP4064462B2 (ja) 2008-03-19
EP0893446A4 (cg-RX-API-DMAC7.html) 1999-01-27
CA2250002A1 (en) 1997-10-16
CN1215403A (zh) 1999-04-28
EP0893446B1 (en) 2006-10-04
KR20000005238A (ko) 2000-01-25

Similar Documents

Publication Publication Date Title
EP0893446B1 (en) Cephem compounds and drugs containing the compounds
JP5852562B2 (ja) 新規なセフェム誘導体
US7696354B2 (en) Cephem compounds having broad antibacterial spectrum
ES2241374T3 (es) Compuesto de cefemo que contienen imidazo (4,5-b) piridiniometilo que tienen un amplio espectro antibacteriano.
TW201020259A (en) Catechol-containing cephalosporins
ES2623501T3 (es) Compuestos antibacterianos
JPWO1997037996A1 (ja) セフェム化合物及び該化合物を含有する医薬
EP0266896B1 (en) 7-( (meta-substituted) phenylglycine) 1-carba-1-dethiacephalosporins
Kim et al. Novel lβ-methylcarbapenems having cyclic sulfonamide moieties: Synthesis and evaluation of in vitro antibacterial activity
US5661144A (en) Cephem derivatives with 3-substituted bis heterocycles
PT77404B (en) Process for preparing new carbapenem antibiotics
TW200530255A (en) 3-pyridiniummethylcefem compound
ES2206257T3 (es) Derivado del acido quinolino-carboxilico o sus sales.
HU197748B (en) Process for producing carbapenem derivatives substituted at the 2-position by quaternizated pyridylthioalkylthio group and pharmaceuticals comprising same as active ingredient
GB2144126A (en) Penem carboxylix acids and the preparation thereof
Ishikawa et al. Synthesis and structure-activity relationships of 1β-methylcarbapenems with quaternary ammonium side chains
JP2004137185A (ja) チオフェン骨格を有する抗菌剤
KR19990008354A (ko) 카르바페넴의 에스테르
ES2226937T3 (es) Oxazolidinonas derivadas de sultama y sultona antibioticas.
EP0481441A2 (en) Novel cephem compounds, their preparation processes and antibacterial agents
ES2211149T3 (es) Derivado de eritromicina con actividad antibiotica.
KR100388785B1 (ko) (3-아미노-4-알킬옥심)피페리딘 치환체를 갖는 신규한 퀴놀론 카
KR100361831B1 (ko) (4-아미노-3-치환된 옥심)피페리딘 치환체를 갖는 신규한 퀴놀론카복실산 유도체
KR19980076903A (ko) 신규한 퀴놀론카르복실산 유도체
JPWO1996005205A1 (ja) 新規セフェム誘導体